Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures (REAFFIRM)

NCT02274857 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT02274857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02274857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures (REAFFIRM)
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2014
Completion date
November 10, 2018
Enrollment
350 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation